David Sibon
18PUBLICATIONS
84CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (18)
Sort by Publication Date:
|Aug 04, 2025
Brentuximab vedotin addition to gemcitabine in relapsed or refractory peripheral T-cell lymphoma: a LYSA phase 2 study.Olivier Tournilhac, Kamal Bouabdallah, Solène Lecolant
|Mar 03, 2025
Interim PET after 4 cycles predicts outcome in histomolecularly confirmed primary mediastinal B-cell lymphoma.Vincent Camus, Thierry Molina, Fabienne Desmots
|Sep 13, 2024
Long-Term Follow-Up of the Prospective Randomized AATT Study (Autologous or Allogeneic Transplantation in Patients With Peripheral T-Cell Lymphoma).Olivier Tournilhac, Bettina Altmann, Birte Friedrichs
|Jun 12, 2024
Brigatinib in ALK-Positive ALCL after Failure of Brentuximab Vedotin.Layla Veleanu, Laurence Lamant, David Sibon
|May 16, 2023
Tandem versus single haematopoietic stem cell transplant and BV maintenance in relapsed/refractory Hodgkin lymphoma: A matched cohort analysis from the LYSA.A Marouf, N Molinari, D Sibon
|Apr 18, 2023
Randomized Phase III Trial Evaluating Subcutaneous Rituximab for the First-Line Treatment of Low-Tumor Burden Follicular Lymphoma: Results of a LYSA Study.Guillaume Cartron, Emmanuel Bachy, Hervé Tilly
Pageof 3
Frequent Collaborators
6 joint publications
Gandhi Laurent Damaj
6 joint publications
Franck Morschhauser
5 joint publications
Olivier Tournilhac
5 joint publications
Roch Houot
5 joint publications
Guillaume Cartron
5 joint publications
René-Olivier Casasnovas
4 joint publications
Vincent Camus
3 joint publications
Luc-Matthieu Fornecker
3 joint publications
Emmanuel Bachy
3 joint publications
Philippe Gaulard
